Kwakwa, H.; Bran, J.; Ruff, J.; Sharaf, S.; Seung, H.; Choe, S.; Chua, J.V.
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study. Viruses 2025, 17, 510.
https://doi.org/10.3390/v17040510
AMA Style
Kwakwa H, Bran J, Ruff J, Sharaf S, Seung H, Choe S, Chua JV.
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study. Viruses. 2025; 17(4):510.
https://doi.org/10.3390/v17040510
Chicago/Turabian Style
Kwakwa, Helena, Jacqueline Bran, Julia Ruff, Salma Sharaf, Hyunuk Seung, Sunny Choe, and Joel V. Chua.
2025. "Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study" Viruses 17, no. 4: 510.
https://doi.org/10.3390/v17040510
APA Style
Kwakwa, H., Bran, J., Ruff, J., Sharaf, S., Seung, H., Choe, S., & Chua, J. V.
(2025). Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study. Viruses, 17(4), 510.
https://doi.org/10.3390/v17040510